According to this study, the global Nucleic Acid-based Drugs market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid-based Drugs market by product type, application, key players and key regions and countries.

Segmentation by product type:

ASO

mRNA

siRNA

miRNA

saRNA

Aptamer

Segmentation by Application:

Genetic Disease

Cancer

Cardiovascular Diseases

Other

This report also splits the market by region:

United States

China

Europe

Other regions:

Japan

South Korea

Southeast Asia

Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

Ionis Pharmaceuticals

Sarepta Therapeutics

Nippon Shinyaku

BioNTech

Moderna Therapeutics

CureVac

Alnylam Pharmaceuticals

Regulus Therapeutics

Miragen Therapeutics

Mina Therapeutics

NeXstar Pharmaceuticals